DNA fragments detected in monovalent and bivalent Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada: Exploratory dose response relationship with serious adverse events
Researchers around the world are identifying contaminants and impurities in the monovalent and bivalent COVID-19 genetic vaccines sold by both
October 25, 2023
